New Initiative to Expand Access and Increase Diversity in Cancer Clinical Trials DURHAM, NC, UNITED STATES, October 17, 2024 /EI ...

The province cut the ribbon Thursday on Calgary's new cancer care centre, one that Premier Danielle Smith and Health Minister ...

However, the market is expected to grow significantly between 2022 and 2032, with a projected growth rate of 7%, which is ...

Data suggest that, in the United States, there is a growing reliance on industry to conduct clinical cancer research.

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

Once the stage has been set, the second phase of Alzheimer’s ensues. People begin to develop overt memory and cognitive ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This process results in deterioration of muscle strength in the limbs and bulbar ...

The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) builds on prior work by Putrino and his colleagues at Mount Sinai.

Alzheimer’s disease may damage the brain in two phases, according to new research published in Nature Neuroscience on Monday.